Back in 2017, Cannabis was still stigmatised and cultivation considered an art form. Built on the 3 core pillars of Safety, Science, and Scale, Cannim established an organisation that could show people that Cannabis was a real medicine, consistently develop it to pharmaceutical standards, and establish networks to reach a wide audience of needy people.
Just 4 years later, Cannim cultivates in Jamaica and Australia, and established a network of EU GMP manufacturers as well as formed alliances in education and healthcare, offering products & services to bring relief in many forms to people across the world.
This industry is nascent and this is only the beginning of the journey to establish Cannabis as a reputable medicine around the world. Cannim continues to create scale in its operations, giving us the ability to meet the needs of the ever-growing body of medicinal cannabis users. Cannim is pioneering the development of the category, creating new ways of administration for patients, leading research and education into the effects of cannabis on a variety of conditions, pioneering its usefulness for others, and ensuring those in need get what they need when they need it at a price that’s fair.
Cannim successfully exported the first legal commercial shipment of cannabis out of Jamaica into the Australian and European markets.
Cannims farm operates a mix of greenhouses, hoop houses and outdoor grow areas, giving us an ongoing harvesting opportunity to continually meet our customers needs. This facility has the capacity to generate over 1 tonne of flower per month.
Cannim is a significant provider of employment opportunities in the local areas and has a passion to help Jamaicans benefit from the growth of an industry they are synonymous with.
This farm operates under the following licences granted by the Australian Office of Drug Control
Cannim is able to circulate products within the whole Australian market using a NSW Wholesale licence (by Indent).
Cannim currently works with manufacturers in: